Results of the national initiative for cancer care quality: How can we improve the quality of cancer care in the United States?

被引:253
作者
Malin, JL
Schneider, EC
Epstein, AM
Adams, J
Emanuel, EJ
Kahn, KL
机构
[1] One Amgen Ctr, Thousand Oaks, CA USA
[2] RAND Corp, Santa Monica, CA USA
[3] Univ Calif Los Angeles, Dept Med, Los Angeles, CA USA
[4] Harvard Univ, Dept Hlth Policy & Management, Cambridge, MA 02138 USA
[5] Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA
[6] Brigham & Womens Hosp, Div Gen Med, Sect Hlth Policy, Boston, MA USA
[7] NIH, Warren G Magnuson Clin Ctr, Dept Clin Bioeth, Bethesda, MD USA
关键词
D O I
10.1200/JCO.2005.03.3365
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose In 1999, the National Cancer Policy Board called attention to the quality of cancer care in the United States and recommended establishing a quality monitoring system with the capability of regularly reporting on the quality of care for patients with cancer. Methods Using data from a patient survey 4 years after diagnosis and review of medical records, we determined the percentage of stage I to III breast cancer and stage II to III colorectal cancer survivors in five metropolitan statistical areas (MSAs) across the United States who received recommended care specified by a comprehensive set of explicit quality measures. Results Two thousand three hundred sixty-six (63%) of 3,775 eligible patients responded to the survey, and 85% consented to have their medical records reviewed. Our final analytic sample (n = 1,765) included 47% of the eligible patients. Patients with breast and colorectal cancer received 86% of recommended care (95% Cl, 86% to 87%) and 78% of recommended care (95% Cl, 77% to 79%), respectively. Adherence to quality measures was less than 85% for 18 of the 36 breast cancer measures, and significant variation across MSAs was observed for seven quality measures. The percent adherence was less than 85% for 14 of the 25 colorectal cancer measures, and one quality measure demonstrated statistically significant variation across the MSAs. Conclusion Initial management of patients with breast and colorectal cancer in the United States seemed consistent with evidence-based practice; however, substantial variation in adherence to some quality measures point to significant opportunities for improvement.
引用
收藏
页码:626 / 634
页数:9
相关论文
共 29 条
[1]  
[Anonymous], 2001, CROSS QUAL CHASM
[2]  
[Anonymous], ERR HUM BUILD SAF HL
[3]  
[Anonymous], 2001, ENV NAT HLTH CAR QUA
[4]  
[Anonymous], AHRQ PUBL
[5]   Determining the quality of breast cancer care: Do tumor registries measure up? [J].
Bickell, NA ;
Chassin, MR .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (09) :705-+
[6]  
Carlson RW, 1999, ONCOLOGY-NY, V13, P41
[7]   Completeness of information on adjuvant therapies for colorectal cancer in population-based cancer registries [J].
Cress, RD ;
Zaslavsky, AM ;
West, DW ;
Wolf, RE ;
Felter, MC ;
Ayanian, JZ .
MEDICAL CARE, 2003, 41 (09) :1006-1012
[8]   Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology [J].
Desch, CE ;
Benson, AB ;
Smith, TJ ;
Flynn, PJ ;
Krause, C ;
Loprinzi, CL ;
Minsky, BD ;
Petrelli, NJ ;
Pfister, DG ;
Somerfield, MR .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) :1312-1321
[9]  
Guadagnoli E, 1998, CANCER-AM CANCER SOC, V83, P302, DOI 10.1002/(SICI)1097-0142(19980715)83:2<302::AID-CNCR14>3.0.CO
[10]  
2-X